ISTIBON Trademark

Trademark Overview

On Thursday, January 2, 2014, a trademark application was filed for ISTIBON with the United States Patent and Trademark Office. The USPTO has given the ISTIBON trademark a serial number of 86156380. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 21, 2017. This trademark is owned by Onconova Therapeutics, Inc.. The ISTIBON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases
istibon

General Information

Serial Number86156380
Word MarkISTIBON
Filing DateThursday, January 2, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 21, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2014

Trademark Statements

Goods and ServicesPharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 16, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOnconova Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewtown, PA 18940
Party NameOnconova Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewtown, PA 18940

Trademark Events

Event DateEvent Description
Thursday, December 21, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 21, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 21, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 14, 2017EXTENSION 5 GRANTED
Friday, January 6, 2017EXTENSION 5 FILED
Friday, January 6, 2017TEAS EXTENSION RECEIVED
Tuesday, July 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 24, 2016EXTENSION 4 GRANTED
Friday, July 8, 2016EXTENSION 4 FILED
Friday, July 8, 2016TEAS EXTENSION RECEIVED
Saturday, February 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 5, 2016EXTENSION 3 GRANTED
Monday, January 4, 2016EXTENSION 3 FILED
Monday, January 4, 2016TEAS EXTENSION RECEIVED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 22, 2015EXTENSION 2 GRANTED
Tuesday, June 23, 2015EXTENSION 2 FILED
Saturday, July 18, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 23, 2015TEAS EXTENSION RECEIVED
Thursday, January 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 6, 2015EXTENSION 1 GRANTED
Tuesday, January 6, 2015EXTENSION 1 FILED
Tuesday, January 6, 2015TEAS EXTENSION RECEIVED
Tuesday, July 15, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 20, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 20, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 3, 2014ASSIGNED TO EXAMINER
Thursday, January 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 6, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

istibon cancer solid cancers tumors diseases hematological pancreatic syndromes drugs namely